 Dylan Taatjes
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 33 | 2025 | 318 | 10.070 |
Why?
| | Mediator Complex | 26 | 2024 | 57 | 9.200 |
Why?
| | Transcription, Genetic | 40 | 2025 | 1418 | 6.910 |
Why?
| | Cyclin-Dependent Kinases | 14 | 2025 | 129 | 6.090 |
Why?
| | Transcription Factors | 28 | 2025 | 1647 | 3.860 |
Why?
| | Cyclin-Dependent Kinase 8 | 13 | 2025 | 43 | 3.480 |
Why?
| | Transcription Factor TFIIH | 9 | 2025 | 39 | 3.330 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2022 | 507 | 2.740 |
Why?
| | Gene Expression Regulation | 22 | 2025 | 2542 | 2.410 |
Why?
| | Transcription Initiation, Genetic | 6 | 2025 | 15 | 2.100 |
Why?
| | Promoter Regions, Genetic | 12 | 2025 | 1207 | 1.560 |
Why?
| | Transcription Factor TFIID | 3 | 2021 | 24 | 1.400 |
Why?
| | Multiprotein Complexes | 5 | 2017 | 155 | 1.200 |
Why?
| | Chromatin | 12 | 2022 | 479 | 1.180 |
Why?
| | Transcriptional Activation | 7 | 2025 | 367 | 1.020 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 281 | 1.000 |
Why?
| | Transcription Initiation Site | 4 | 2021 | 43 | 0.950 |
Why?
| | Protein Binding | 19 | 2024 | 2124 | 0.910 |
Why?
| | Antibiotics, Antineoplastic | 7 | 2001 | 123 | 0.890 |
Why?
| | Transcription Factors, TFII | 4 | 2015 | 40 | 0.870 |
Why?
| | Interferons | 1 | 2025 | 191 | 0.840 |
Why?
| | Cryoelectron Microscopy | 8 | 2025 | 179 | 0.810 |
Why?
| | Cell Nucleus | 7 | 2021 | 584 | 0.780 |
Why?
| | Protein Subunits | 8 | 2015 | 233 | 0.750 |
Why?
| | Saccharomyces cerevisiae | 6 | 2022 | 530 | 0.750 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2022 | 383 | 0.730 |
Why?
| | Doxorubicin | 8 | 2000 | 329 | 0.730 |
Why?
| | Trans-Activators | 6 | 2011 | 393 | 0.710 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 887 | 0.700 |
Why?
| | Humans | 70 | 2025 | 129626 | 0.650 |
Why?
| | Cell Proliferation | 2 | 2025 | 2373 | 0.630 |
Why?
| | Daunorubicin | 7 | 2000 | 26 | 0.630 |
Why?
| | Phosphorylation | 10 | 2025 | 1713 | 0.620 |
Why?
| | Drosophila | 1 | 2020 | 141 | 0.610 |
Why?
| | Signal Transduction | 8 | 2025 | 4931 | 0.610 |
Why?
| | Phosphoproteins | 2 | 2023 | 335 | 0.600 |
Why?
| | Phenanthrenes | 1 | 2018 | 12 | 0.590 |
Why?
| | Down Syndrome | 1 | 2025 | 478 | 0.590 |
Why?
| | Drosophila Proteins | 1 | 2020 | 185 | 0.590 |
Why?
| | Diterpenes | 1 | 2018 | 32 | 0.590 |
Why?
| | Molecular Biology | 1 | 2018 | 56 | 0.580 |
Why?
| | Biophysics | 1 | 2018 | 68 | 0.570 |
Why?
| | Cell Line | 9 | 2025 | 2784 | 0.560 |
Why?
| | Formaldehyde | 6 | 2000 | 60 | 0.550 |
Why?
| | Polycyclic Compounds | 2 | 2016 | 13 | 0.540 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 21 | 0.530 |
Why?
| | Osteosarcoma | 1 | 2017 | 70 | 0.520 |
Why?
| | Animals | 28 | 2025 | 35391 | 0.520 |
Why?
| | Models, Biological | 3 | 2020 | 1724 | 0.520 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2015 | 7 | 0.500 |
Why?
| | Porins | 1 | 2015 | 12 | 0.500 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2015 | 5 | 0.480 |
Why?
| | E1A-Associated p300 Protein | 1 | 2015 | 8 | 0.480 |
Why?
| | Mediator Complex Subunit 1 | 3 | 2020 | 4 | 0.480 |
Why?
| | HeLa Cells | 11 | 2019 | 612 | 0.470 |
Why?
| | RNA | 1 | 2021 | 882 | 0.470 |
Why?
| | Bone Neoplasms | 1 | 2017 | 229 | 0.460 |
Why?
| | Leiomyoma | 1 | 2015 | 73 | 0.440 |
Why?
| | Estrogen Receptor alpha | 1 | 2015 | 130 | 0.440 |
Why?
| | Protein Kinases | 1 | 2016 | 318 | 0.440 |
Why?
| | Uterine Neoplasms | 1 | 2015 | 101 | 0.430 |
Why?
| | DNA | 7 | 2022 | 1404 | 0.430 |
Why?
| | Protein Conformation | 7 | 2021 | 863 | 0.430 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 398 | 0.430 |
Why?
| | Protein Structure, Quaternary | 4 | 2021 | 122 | 0.410 |
Why?
| | Epirubicin | 4 | 2002 | 4 | 0.400 |
Why?
| | Antineoplastic Agents | 7 | 2020 | 2046 | 0.390 |
Why?
| | DNA Helicases | 4 | 2022 | 148 | 0.390 |
Why?
| | HCT116 Cells | 4 | 2021 | 78 | 0.380 |
Why?
| | Genes, p53 | 3 | 2021 | 70 | 0.370 |
Why?
| | Enhancer Elements, Genetic | 5 | 2024 | 176 | 0.370 |
Why?
| | Enzyme Activation | 3 | 2020 | 813 | 0.370 |
Why?
| | DNA Repair | 4 | 2022 | 210 | 0.340 |
Why?
| | Imidazoles | 3 | 2021 | 234 | 0.340 |
Why?
| | Histones | 3 | 2015 | 589 | 0.330 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 64 | 0.330 |
Why?
| | Proteomics | 1 | 2016 | 1055 | 0.320 |
Why?
| | Mass Spectrometry | 9 | 2015 | 714 | 0.320 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 1445 | 0.320 |
Why?
| | Tumor Cells, Cultured | 8 | 2017 | 943 | 0.310 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.310 |
Why?
| | Cell Cycle | 2 | 2025 | 588 | 0.310 |
Why?
| | Piperazines | 3 | 2021 | 340 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1336 | 0.310 |
Why?
| | Models, Molecular | 8 | 2015 | 1491 | 0.300 |
Why?
| | DNA Adducts | 5 | 1999 | 16 | 0.290 |
Why?
| | Serine | 3 | 2023 | 138 | 0.290 |
Why?
| | Histone Acetyltransferases | 1 | 2008 | 60 | 0.280 |
Why?
| | Nuclear Proteins | 4 | 2020 | 660 | 0.280 |
Why?
| | Mitochondria | 1 | 2013 | 876 | 0.270 |
Why?
| | Repressor Proteins | 2 | 2014 | 406 | 0.270 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 29 | 0.270 |
Why?
| | Recombinant Proteins | 5 | 2020 | 1308 | 0.260 |
Why?
| | Protein Isoforms | 2 | 2021 | 388 | 0.260 |
Why?
| | Proteome | 2 | 2023 | 438 | 0.240 |
Why?
| | Crystallography, X-Ray | 4 | 2017 | 438 | 0.240 |
Why?
| | Substrate Specificity | 3 | 2023 | 371 | 0.240 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 399 | 0.240 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 179 | 0.240 |
Why?
| | Genes, Regulator | 1 | 2004 | 34 | 0.230 |
Why?
| | Protein Structure, Tertiary | 6 | 2013 | 843 | 0.220 |
Why?
| | Receptors, Calcitriol | 1 | 2004 | 53 | 0.220 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2020 | 752 | 0.210 |
Why?
| | Aging | 1 | 2013 | 1778 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2019 | 772 | 0.210 |
Why?
| | Threonine | 1 | 2023 | 44 | 0.200 |
Why?
| | Escherichia coli | 2 | 2017 | 767 | 0.200 |
Why?
| | Yeasts | 1 | 2022 | 52 | 0.200 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 3 | 2010 | 6 | 0.190 |
Why?
| | DNA, Neoplasm | 2 | 1999 | 157 | 0.190 |
Why?
| | Molecular Probes | 1 | 2022 | 36 | 0.190 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 314 | 0.190 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2010 | 57 | 0.190 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 269 | 0.180 |
Why?
| | Nucleic Acid Conformation | 5 | 2016 | 706 | 0.180 |
Why?
| | HL-60 Cells | 1 | 2020 | 34 | 0.180 |
Why?
| | Mammals | 1 | 2022 | 275 | 0.170 |
Why?
| | Fluorouracil | 1 | 2021 | 197 | 0.170 |
Why?
| | Cell Survival | 2 | 2020 | 1076 | 0.170 |
Why?
| | Software | 1 | 2025 | 608 | 0.170 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 317 | 0.160 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.160 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 42 | 0.160 |
Why?
| | Genome, Human | 1 | 2021 | 394 | 0.160 |
Why?
| | Genetic Variation | 1 | 2004 | 939 | 0.150 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2018 | 16 | 0.150 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2018 | 30 | 0.150 |
Why?
| | Alternative Splicing | 1 | 2020 | 217 | 0.150 |
Why?
| | Alkylating Agents | 1 | 1998 | 24 | 0.150 |
Why?
| | Anthracyclines | 1 | 1998 | 49 | 0.150 |
Why?
| | Epoxy Compounds | 1 | 2018 | 33 | 0.150 |
Why?
| | Bacterial Proteins | 1 | 2004 | 836 | 0.150 |
Why?
| | Fibroblasts | 3 | 2019 | 953 | 0.140 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2025 | 54 | 0.140 |
Why?
| | RNA Splicing | 1 | 2019 | 260 | 0.140 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 18 | 0.140 |
Why?
| | Mutation | 3 | 2021 | 3717 | 0.140 |
Why?
| | STAT1 Transcription Factor | 2 | 2019 | 69 | 0.140 |
Why?
| | Drug Design | 1 | 1998 | 158 | 0.140 |
Why?
| | Cell Cycle Proteins | 4 | 2020 | 584 | 0.140 |
Why?
| | Biology | 1 | 2018 | 84 | 0.140 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2017 | 44 | 0.130 |
Why?
| | Research | 1 | 2020 | 419 | 0.130 |
Why?
| | DNA Damage | 1 | 2019 | 384 | 0.130 |
Why?
| | Peptides | 1 | 2022 | 926 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 880 | 0.130 |
Why?
| | HEK293 Cells | 5 | 2019 | 698 | 0.130 |
Why?
| | Mitosis | 1 | 2017 | 180 | 0.130 |
Why?
| | RNA, Bacterial | 1 | 2017 | 182 | 0.130 |
Why?
| | Neoplasms | 2 | 2020 | 2455 | 0.130 |
Why?
| | Genes, Neoplasm | 1 | 2015 | 20 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 422 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 431 | 0.120 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 124 | 0.120 |
Why?
| | Glutathione | 2 | 2013 | 348 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2017 | 321 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2020 | 116 | 0.120 |
Why?
| | Cholesterol | 1 | 2017 | 412 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 876 | 0.120 |
Why?
| | Alkylation | 4 | 1999 | 24 | 0.120 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 827 | 0.110 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2014 | 69 | 0.110 |
Why?
| | Models, Genetic | 2 | 2011 | 593 | 0.110 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 323 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2015 | 139 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 67 | 0.110 |
Why?
| | RNA, Untranslated | 1 | 2015 | 118 | 0.110 |
Why?
| | Unfolded Protein Response | 1 | 2013 | 53 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 37 | 0.100 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 7 | 0.100 |
Why?
| | RNA-Binding Protein FUS | 1 | 2012 | 13 | 0.100 |
Why?
| | Macromolecular Substances | 2 | 2004 | 216 | 0.100 |
Why?
| | Epigenomics | 1 | 2013 | 110 | 0.100 |
Why?
| | Cell Line, Tumor | 5 | 2024 | 3186 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 1997 | 580 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2835 | 0.090 |
Why?
| | Protein Biosynthesis | 1 | 2013 | 410 | 0.090 |
Why?
| | Pyrococcus furiosus | 1 | 2010 | 3 | 0.090 |
Why?
| | Protein Multimerization | 1 | 2012 | 179 | 0.090 |
Why?
| | Transcription Factor TFIIB | 1 | 2010 | 13 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 179 | 0.090 |
Why?
| | Archaeal Proteins | 1 | 2010 | 49 | 0.080 |
Why?
| | DNA, Single-Stranded | 1 | 2011 | 113 | 0.080 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 217 | 0.080 |
Why?
| | Biochemistry | 1 | 2010 | 38 | 0.080 |
Why?
| | Serum Response Factor | 1 | 2010 | 31 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2011 | 102 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 1998 | 1028 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2010 | 114 | 0.080 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2010 | 100 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2057 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 361 | 0.080 |
Why?
| | DNA Polymerase II | 1 | 2009 | 38 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2016 | 2708 | 0.080 |
Why?
| | Pol1 Transcription Initiation Complex Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| | Coenzymes | 1 | 2008 | 20 | 0.080 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 596 | 0.080 |
Why?
| | Cell Lineage | 2 | 2024 | 331 | 0.080 |
Why?
| | Telomere | 1 | 2011 | 233 | 0.080 |
Why?
| | Cyclins | 1 | 2008 | 89 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1465 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3080 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1087 | 0.070 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 423 | 0.070 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 132 | 0.070 |
Why?
| | Protein Domains | 2 | 2019 | 256 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 457 | 0.070 |
Why?
| | Dithiothreitol | 2 | 1997 | 17 | 0.070 |
Why?
| | Acetylation | 1 | 2008 | 244 | 0.070 |
Why?
| | Vesiculovirus | 2 | 2019 | 16 | 0.070 |
Why?
| | Mice | 7 | 2019 | 16961 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3152 | 0.060 |
Why?
| | Microscopy, Electron | 3 | 2002 | 426 | 0.060 |
Why?
| | Hydrogen Peroxide | 2 | 1997 | 317 | 0.060 |
Why?
| | Cell Division | 2 | 2015 | 796 | 0.060 |
Why?
| | STAT3 Transcription Factor | 2 | 2019 | 194 | 0.060 |
Why?
| | Vitamin D Response Element | 1 | 2004 | 1 | 0.060 |
Why?
| | Sp1 Transcription Factor | 1 | 2004 | 24 | 0.060 |
Why?
| | Hydrolysis | 3 | 2002 | 186 | 0.060 |
Why?
| | Binding Sites | 2 | 2004 | 1248 | 0.050 |
Why?
| | Kinetics | 2 | 2016 | 1645 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1687 | 0.050 |
Why?
| | Phosphothreonine | 1 | 2023 | 6 | 0.050 |
Why?
| | Phosphoserine | 1 | 2023 | 34 | 0.050 |
Why?
| | Species Specificity | 1 | 2004 | 574 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2023 | 109 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2002 | 651 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2002 | 98 | 0.050 |
Why?
| | Cross-Linking Reagents | 3 | 2015 | 205 | 0.050 |
Why?
| | TATA-Box Binding Protein | 2 | 2013 | 20 | 0.050 |
Why?
| | Mutagenesis | 1 | 2022 | 181 | 0.050 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2002 | 66 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2021 | 63 | 0.040 |
Why?
| | Base Sequence | 2 | 2016 | 2147 | 0.040 |
Why?
| | Oligonucleotides | 2 | 1999 | 143 | 0.040 |
Why?
| | Breast | 1 | 2021 | 153 | 0.040 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2020 | 22 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2004 | 466 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 161 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2019 | 5 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2021 | 148 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2019 | 43 | 0.040 |
Why?
| | STAT Transcription Factors | 1 | 2019 | 14 | 0.040 |
Why?
| | Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 13 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 1999 | 86 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 52 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2019 | 76 | 0.040 |
Why?
| | Dexamethasone | 1 | 2021 | 350 | 0.040 |
Why?
| | Models, Chemical | 2 | 1997 | 263 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 163 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 388 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 479 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 528 | 0.040 |
Why?
| | Drug Carriers | 1 | 1999 | 119 | 0.040 |
Why?
| | Chemistry, Pharmaceutical | 1 | 1998 | 107 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 170 | 0.040 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 156 | 0.040 |
Why?
| | Synaptic Vesicles | 1 | 1998 | 42 | 0.040 |
Why?
| | Buffers | 1 | 1997 | 56 | 0.040 |
Why?
| | Breast Neoplasms | 2 | 2000 | 2133 | 0.040 |
Why?
| | beta Catenin | 1 | 2019 | 225 | 0.040 |
Why?
| | Anaerobiosis | 1 | 1997 | 57 | 0.040 |
Why?
| | Oxazoles | 1 | 1997 | 30 | 0.030 |
Why?
| | Nucleic Acids | 1 | 1998 | 61 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1998 | 191 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1997 | 109 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 740 | 0.030 |
Why?
| | Xanthine Oxidase | 1 | 1997 | 78 | 0.030 |
Why?
| | NAD | 1 | 1997 | 75 | 0.030 |
Why?
| | Uridine Triphosphate | 1 | 2016 | 12 | 0.030 |
Why?
| | Molecular Structure | 1 | 1998 | 481 | 0.030 |
Why?
| | Sulfhydryl Reagents | 1 | 1996 | 12 | 0.030 |
Why?
| | Computer Simulation | 1 | 2021 | 939 | 0.030 |
Why?
| | Computational Biology | 1 | 2021 | 596 | 0.030 |
Why?
| | Fluorescence | 1 | 2017 | 155 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1996 | 84 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1998 | 541 | 0.030 |
Why?
| | Guanosine Triphosphate | 1 | 2016 | 92 | 0.030 |
Why?
| | Female | 5 | 2021 | 68734 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 356 | 0.030 |
Why?
| | Oxidants | 1 | 1996 | 109 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2016 | 332 | 0.030 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 539 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2015 | 7 | 0.030 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2015 | 19 | 0.030 |
Why?
| | Genes, Tumor Suppressor | 1 | 2015 | 87 | 0.030 |
Why?
| | Iron | 1 | 1997 | 282 | 0.030 |
Why?
| | Flow Cytometry | 1 | 1999 | 1159 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 406 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2021 | 1075 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2014 | 19 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 350 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 15 | 0.030 |
Why?
| | Tripartite Motif-Containing Protein 28 | 1 | 2014 | 14 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 66 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 1998 | 569 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2013 | 12 | 0.030 |
Why?
| | Mental Retardation, X-Linked | 1 | 2013 | 13 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 636 | 0.030 |
Why?
| | Muscle Hypotonia | 1 | 2013 | 32 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2013 | 61 | 0.030 |
Why?
| | Anus, Imperforate | 1 | 2013 | 24 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2013 | 48 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 141 | 0.020 |
Why?
| | Ubiquitination | 1 | 2013 | 98 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 2881 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 840 | 0.020 |
Why?
| | Proteolysis | 1 | 2013 | 167 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2013 | 265 | 0.020 |
Why?
| | Constipation | 1 | 2013 | 88 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1998 | 1125 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2011 | 84 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 756 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2010 | 15 | 0.020 |
Why?
| | Serum Response Element | 1 | 2010 | 5 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 146 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 296 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2010 | 88 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 341 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 387 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 108 | 0.020 |
Why?
| | Neurons | 1 | 1998 | 1494 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5455 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 723 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2012 | 851 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1206 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2627 | 0.020 |
Why?
| | Sialic Acids | 1 | 1985 | 9 | 0.020 |
Why?
| | Sialyltransferases | 1 | 1985 | 13 | 0.020 |
Why?
| | Transferases | 1 | 1985 | 33 | 0.020 |
Why?
| | Golgi Apparatus | 1 | 1985 | 100 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 4084 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2002 | 102 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 327 | 0.010 |
Why?
| | Immunoblotting | 1 | 2002 | 305 | 0.010 |
Why?
| | Male | 2 | 2015 | 63670 | 0.010 |
Why?
| | Cell Death | 1 | 2002 | 354 | 0.010 |
Why?
| | Ligands | 1 | 2002 | 621 | 0.010 |
Why?
| | Intercalating Agents | 1 | 1999 | 5 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 315 | 0.010 |
Why?
| | Qa-SNARE Proteins | 1 | 1998 | 14 | 0.010 |
Why?
| | R-SNARE Proteins | 1 | 1998 | 19 | 0.010 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 1998 | 26 | 0.010 |
Why?
| | Microscopy, Atomic Force | 1 | 1998 | 118 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 192 | 0.010 |
Why?
| | Catalysis | 1 | 1997 | 310 | 0.010 |
Why?
| | Rats | 2 | 1998 | 5483 | 0.010 |
Why?
| | Cell Membrane | 1 | 1998 | 734 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1998 | 2395 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4078 | 0.010 |
Why?
| | Thiamine Pyrophosphatase | 1 | 1985 | 1 | 0.000 |
Why?
| | Nucleotidases | 1 | 1985 | 7 | 0.000 |
Why?
| | Immunologic Techniques | 1 | 1985 | 39 | 0.000 |
Why?
| | Glycoproteins | 1 | 1985 | 338 | 0.000 |
Why?
| | Liver | 1 | 1985 | 1842 | 0.000 |
Why?
|
|
Taatjes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|